Palisade Bio Stock Technical Analysis

PALI Stock  USD 1.73  0.01  0.57%   
As of the 14th of February 2026, Palisade Bio holds the Semi Deviation of 6.39, risk adjusted performance of 0.0326, and Coefficient Of Variation of 3391.51. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Palisade Bio, as well as the relationship between them.

Palisade Bio Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Palisade, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PalisadePalisade Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Palisade Bio Analyst Consensus

Target PriceConsensus# of Analysts
13.4Strong Buy3Odds
Palisade Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Palisade analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Palisade stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Palisade Bio, talking to its executives and customers, or listening to Palisade conference calls.
Palisade Analyst Advice Details
Is there potential for Biotechnology market expansion? Will Palisade introduce new products? Factors like these will boost the valuation of Palisade Bio. Anticipated expansion of Palisade directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Return On Assets
(0.88)
Return On Equity
(2.29)
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Palisade Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Palisade Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Palisade Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Palisade Bio 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Palisade Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Palisade Bio.
0.00
11/16/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/14/2026
0.00
If you would invest  0.00  in Palisade Bio on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Palisade Bio or generate 0.0% return on investment in Palisade Bio over 90 days. Palisade Bio is related to or competes with Aspire BioPharma, Curis, Processa Pharmaceuticals, Briacell Therapeutics, Hoth Therapeutics, Citius Pharmaceuticals, and Dare Bioscience. Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing ... More

Palisade Bio Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Palisade Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Palisade Bio upside and downside potential and time the market with a certain degree of confidence.

Palisade Bio Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Palisade Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Palisade Bio's standard deviation. In reality, there are many statistical measures that can use Palisade Bio historical prices to predict the future Palisade Bio's volatility.
Hype
Prediction
LowEstimatedHigh
0.091.728.51
Details
Intrinsic
Valuation
LowRealHigh
0.234.6111.40
Details
3 Analysts
Consensus
LowTargetHigh
12.1913.4014.87
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.37-0.13-0.04
Details

Palisade Bio February 14, 2026 Technical Indicators

Palisade Bio Backtested Returns

Palisade Bio maintains Sharpe Ratio (i.e., Efficiency) of close to zero, which implies the firm had a close to zero % return per unit of risk over the last 3 months. Palisade Bio exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Palisade Bio's Coefficient Of Variation of 3391.51, semi deviation of 6.39, and Risk Adjusted Performance of 0.0326 to confirm the risk estimate we provide. The company holds a Beta of -0.0525, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Palisade Bio are expected to decrease at a much lower rate. During the bear market, Palisade Bio is likely to outperform the market. At this point, Palisade Bio has a negative expected return of -0.0668%. Please make sure to check Palisade Bio's downside variance, and the relationship between the treynor ratio and kurtosis , to decide if Palisade Bio performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.28  

Poor predictability

Palisade Bio has poor predictability. Overlapping area represents the amount of predictability between Palisade Bio time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Palisade Bio price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Palisade Bio price fluctuation can be explain by its past prices.
Correlation Coefficient0.28
Spearman Rank Test-0.16
Residual Average0.0
Price Variance0.05
Palisade Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Palisade Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Palisade Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Palisade Bio Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Palisade Bio across different markets.

About Palisade Bio Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Palisade Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Palisade Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Palisade Bio price pattern first instead of the macroeconomic environment surrounding Palisade Bio. By analyzing Palisade Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Palisade Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Palisade Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Interest Debt Per Share0.150.14
Revenue Per Share0.630.6

Palisade Bio February 14, 2026 Technical Indicators

Most technical analysis of Palisade help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Palisade from various momentum indicators to cycle indicators. When you analyze Palisade charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Palisade Bio February 14, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Palisade stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Palisade Stock analysis

When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities